Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Directed walk designs for dose-response problems with competing failure modes.

Janis Hardwick1, Mary C Meyer, Quentin F Stout

  • 1EECS Department, University of Michigan, Ann Arbor, Michigan 48109, USA. jphard@umich.edu

Biometrics
|August 21, 2003
PubMed
Summary

This study introduces novel adaptive designs for early-phase clinical trials to find optimal drug doses. These methods balance treatment efficacy and safety, aiming to ethically and accurately identify the best therapeutic dose.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shape selection in Landsat time series: a tool for monitoring forest dynamics.

Global change biology·2016
Same author

Block-structured adaptive meshes and reduced grids for atmospheric general circulation models.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2009
Same author

A critical pathway for patients with acute chest pain and low risk for short-term adverse cardiac events: role of outpatient stress testing.

Annals of emergency medicine·2006
Same author

Prevalence and degree of childhood and adolescent overweight in rural, urban, and suburban Georgia.

The Journal of school health·2006

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Pharmacology

Background:

  • Determining optimal therapeutic doses in early-phase clinical trials is complex.
  • Subjects may experience treatment failure due to lack of efficacy or toxic reactions.
  • Balancing efficacy and toxicity is crucial for subject safety and trial success.

Purpose of the Study:

  • To develop and evaluate adaptive allocation designs for identifying optimal therapeutic doses.
  • To maximize the product of nontoxicity and efficacy dose-response curves.
  • To ensure experimental subjects receive doses close to the maximum effective and safe level.

Main Methods:

  • Proposed novel adaptive designs combining 'directed walks' allocation policies.
  • Utilized new smoothed shape-constrained curve-fitting techniques.

Related Experiment Videos

  • Compared proposed methods against existing techniques, including up-and-down and equal allocation rules.

    • Main Results:

    • The proposed adaptive designs aim to improve the identification of optimal doses.
    • These methods are designed to ethically treat subjects closer to the optimal dose.
    • Performance was evaluated against established dose-finding strategies.

    Conclusions:

    • Adaptive allocation designs offer a promising approach for optimizing dose-finding in early-phase trials.
    • The new methods balance ethical considerations with statistical rigor.
    • Further research can refine these techniques for broader clinical application.